Andrea Tubaro | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Residents and Consultants Have Equal Outcomes When Performing Transrectal Fusion Biopsies: A Randomized Clinical Trial	CURRENT ONCOLOGY	2024
Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries	UROLOGY	2024
Quality of information and appropriateness of Open AI outputs for prostate cancer	PROSTATE CANCER AND PROSTATIC DISEASES	2024
Yoga, benign prostatic hyperplasia and lower urinary tract symptoms: a new path for clinical trials	PROSTATE CANCER AND PROSTATIC DISEASES	2024
Sexual and reproductive health: level of knowledge and source of information in adolescence	JOURNAL OF SEXUAL MEDICINE	2024
Open versus Minimally Invasive Partial Nephrectomy: Trends and Outcomes from a Wide National Population-Based Database	JOURNAL OF CLINICAL MEDICINE	2024
Renal Function Preservation in Purely Off-Clamp Sutureless Robotic Partial Nephrectomy: Initial Experience and Technique	DIAGNOSTICS	2024
Purely Off-Clamp Sutureless Robotic Partial Nephrectomy for Novice Robotic Surgeons: A Multi-Institutional Propensity Score-Matched Analysis	JOURNAL OF CLINICAL MEDICINE	2024
Trends and incidence of reported events associated with ureteral stents: an analysis of the food and drug administration's manufacturer and user facility device experience (MAUDE) database	WORLD JOURNAL OF UROLOGY	2024
Post-Voided Residual Ratio Does Not Predict Trifecta Outcome after Transurethral Resection of Prostate	LIFE	2024
Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH	PROSTATE CANCER AND PROSTATIC DISEASES	2024
Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database	MINERVA UROLOGY AND NEPHROLOGY	2024
Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review	JOURNAL OF CLINICAL MEDICINE	2023
Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2	CANCERS	2023
Physical Inactivity, Metabolic Syndrome and Prostate Cancer Diagnosis: Development of a Predicting Nomogram	METABOLITES	2023
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries	PROSTATE CANCER AND PROSTATIC DISEASES	2023
Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram	CLINICAL GENITOURINARY CANCER	2023
Medications mostly associated with hematuria: assessment of the EudraVigilance and Food and Drug Administration pharmacovigilance databases entries	MINERVA UROLOGY AND NEPHROLOGY	2023
Is EMA warning on quinolones and fluoroquinolones really assessed? An EudraVigilance database analysis	MINERVA UROLOGY AND NEPHROLOGY	2023
Oncological Outcomes of Patients with High-Volume mCRPC: Results from a Longitudinal Real-Life Multicenter Cohort	CANCERS	2023

1
2
3
4
5
6
7
8
9
10
11
seguente ›
ultima »

Progetti di Ricerca

Effetti della combinazione sequenziale di Mitomicina e Bacillo di Calmette e Guérin rispetto alla monoterapia con Bacillo di Calmette e Guérin nel trattamento del carcinoma uroteliale non muscolo invasivo di alto grado con alto rischio di progressione